A sample’s scientific value depends on knowing exactly where it has been. Chain of custody is the documented, unbroken record of who has possessed, handled, or had access to a physical research sample from the moment it is collected until it is consumed, archived, or destroyed. In a research lab, a chain-of-custody (CoC) record answers four questions for every handoff: who had the sample, when, what they did with it, and what condition it was in.
This is a distinct concept from general inventory tracking (knowing a sample exists and where it currently sits) and from the forensic/legal “chain of custody” that dominates search results for the bare term — evidence handling for law enforcement. Research chain of custody borrows the same underlying logic but exists to protect scientific and regulatory integrity, not admissibility in court, though the two do overlap when a study involves controlled substances, contested intellectual property, or litigation-adjacent findings.
What a Sample Chain-of-Custody Record Documents
A complete CoC record for a research sample typically captures:
- Unique sample identifier — a barcode, accession number, or other ID that ties every custody event back to one specific specimen, aliquot, or container.
- Custodian identity — the named individual (not just “the lab”) who took possession at each step.
- Timestamp — date and time of each transfer, collection, or access event.
- Action taken — collected, aliquoted, transported, stored, thawed, analyzed, returned to storage, or destroyed.
- Condition and environment — storage temperature, packaging integrity, and any deviations noted at handoff.
- Signature or electronic authentication — a way to confirm the custodian record is attributable and, where required, tamper-evident.
Missing any one of these creates a gap. A chain of custody with an unexplained gap is functionally broken — a reviewer, auditor, or collaborating lab cannot verify what happened to the sample during that interval, which undermines confidence in any result derived from it.
Why It Matters in a Research Setting
Formal custody documentation isn’t paperwork for its own sake. It exists because several real research risks depend on being able to answer “who had this and when”:
- Reproducibility and data integrity. If a sample was mishandled, degraded, or swapped, results derived from it are unreliable — a documented custody trail is often the only way to retroactively identify where a data-quality problem originated.
- Biorepository and biobank accreditation. The College of American Pathologists’ Biorepository Accreditation Program (CAP-BAP) checklist includes explicit standards for specimen chain of custody as part of its broader requirements for biorepositories handling human biospecimens.
- CLIA and CAP-regulated testing. Where a research sample crosses into clinical laboratory testing under CLIA, or where the lab operates under Good Clinical Laboratory Practice (GCLP) expectations, documented custody and specimen integrity records are a standard element of quality-system audits.
- Sponsor and funder requirements. Industry-sponsored studies, multi-site consortia, and studies moving samples under a material transfer agreement (MTA) frequently require documented custody as a contractual condition, independent of any regulatory mandate.
- Legal and IP disputes. Samples tied to patent priority, misconduct investigations, or contested authorship of a discovery may need to withstand the same scrutiny as forensic evidence — an intact custody trail is the difference between a defensible record and an unsupported claim.
When You Actually Need Formal Chain-of-Custody Documentation
Not every sample in a lab needs the full custody-log treatment. A shared reagent bottle or a routine aliquot for a same-day assay usually doesn’t. Formal, auditable custody documentation becomes necessary when one or more of these apply:
- The sample is a human biospecimen governed by CLIA, CAP, IRB, or biorepository accreditation requirements.
- The sample was collected or is being used under a sponsor agreement, grant terms, or an MTA that specifies custody or traceability obligations.
- The sample involves a controlled substance, select agent, or other material subject to DEA, CDC, or institutional biosafety oversight.
- The sample or its derived data could become part of a research misconduct inquiry, IP dispute, or litigation.
- The sample moves between institutions, cores, or contract labs, where no single party has continuous physical oversight.
Outside those situations, a lighter-touch inventory record (see below) is usually proportionate, and treating every routine sample as if it needs full custodial documentation just creates paperwork nobody will maintain consistently — which defeats the purpose.
Chain of Custody vs. General Sample Inventory Tracking
These two concepts get conflated but answer different questions. Inventory tracking answers “what do we have and where is it right now?” Chain of custody answers “who has had access to this specific item, in what order, and can we prove it?” A barcode or RFID inventory system is genuinely useful infrastructure for chain of custody — a unique scannable ID at each handoff is far more reliable than a handwritten log — but scanning a sample into a freezer location is not, by itself, a custody record unless the system also captures who performed the scan and links each event into an unbroken sequence. A LIMS or inventory platform becomes a true chain-of-custody tool only when it enforces per-user authentication at each transaction, timestamps automatically, and prevents retroactive editing of prior entries.
Building a Chain-of-Custody Process
1. Define the trigger
Decide, in writing, which sample categories require formal custody documentation using the criteria above, and which don’t. An inconsistently applied policy is worse than a narrow, clearly scoped one, because it creates gaps that look like violations during an audit.
2. Standardize the record
Use a consistent form — paper log, spreadsheet, or LIMS module — that captures every field listed above every time, for every sample in scope. Consistency matters more than the specific tool.
3. Assign named custodians, not roles
“Lab tech on duty” is not a custodian. Every handoff needs a specific person’s name or authenticated login, even in a busy shared facility.
4. Document condition at every transfer
Record temperature, packaging state, and any visible anomaly at each handoff — this is especially important for cold-chain shipments of biological reagents, where a temperature excursion during transit can compromise the sample even if physical custody was never in question.
5. Close the loop at disposition
The record should end explicitly — sample consumed, archived, transferred out under an MTA, or destroyed — with the same level of documentation as the original collection event. An open-ended custody record with no documented endpoint is itself a gap.
Common Gaps That Break a Chain of Custody
- Verbal handoffs. A sample physically passed between two people with nothing recorded until it’s logged into storage later — the gap in between is unaccounted for.
- Shared logins. If a LIMS entry can be made under a generic account, the record can’t attribute the action to a specific custodian.
- Undocumented courier legs. A sample shipped between sites often has a clean origin record and a clean receipt record but no visibility into what happened during transport — pair custody documentation with shipment tracking and temperature logging to close this gap.
- Retroactive edits. A custody log that can be silently altered after the fact isn’t a reliable record, regardless of how complete the fields look.
- No documented destruction or final disposition. Samples that simply stop appearing in the log, without an explicit closing entry, leave the chain unresolved.
Frequently Asked Questions
What is chain of custody in a research lab?
It’s the documented, unbroken record of every person who has had possession of or access to a physical sample, and what they did with it, from collection through final disposition (use, archiving, or destruction).
Is chain of custody required for all research samples?
No. It’s generally required or strongly advisable for human biospecimens under CLIA/CAP or IRB oversight, samples covered by a sponsor agreement or MTA, controlled substances and select agents, and any sample that could become relevant to a misconduct inquiry or IP dispute. Routine internal reagents and aliquots typically don’t need full custodial documentation.
What’s the difference between chain of custody and sample inventory tracking?
Inventory tracking tells you what you have and where it currently is. Chain of custody tells you who has handled it, in what sequence, with what actions taken, and can prove there are no unaccounted-for gaps in that sequence.
Does CLIA require chain of custody documentation?
CLIA-regulated clinical laboratory testing carries specimen integrity and identification requirements that function as a chain-of-custody obligation in practice, and CAP’s laboratory and biorepository accreditation checklists include specific chain-of-custody standards. Purely internal, non-clinical research samples aren’t automatically subject to CLIA, but institutions frequently apply similar documentation discipline voluntarily to protect data integrity.
Can a barcode or RFID system serve as a chain-of-custody record?
It can be the backbone of one, but only if the system requires per-user authentication at each scan, timestamps automatically, and doesn’t allow prior entries to be silently edited. A shared-login barcode scan that only logs a freezer location isn’t a complete custody record on its own.
